We entered the India market in late 2022 and are excited to help write a new chapter in providing innovative, high-quality Specialty medicines for Indian patients and families. Today, we’re making healthy possible through our hospital injectables as well as growing portfolios of ophthalmic and oncology medicines.
Since 2008, we’ve been producing medicines for the U.S. market – a global leader and the gold standard in pharmaceutical quality. Today we’re bringing that same Amneal quality commitment to India patients and families. Why? We recognize patient lives depend on it and believe you deserve the best, highest quality medicines.